Increased prevalence of symptomatic macrovascular disease in systemic sclerosis.

D J Veale, T A Collidge, J J Belch

University Department of Medicine, Ninewells Hospital, Dundee, United Kingdom.

OBJECTIVES--To determine the prevalence of symptomatic macrovascular disease, as defined by the World Health Organisation questionnaire for intermittent claudication, in patients with systemic sclerosis (SSc), and to compare the prevalence in this population with a cross sectional population study group reported in the Edinburgh Artery Study (EAS). METHODS--A group of 53 patients with a diagnosis of limited or diffuse systemic sclerosis were identified from our register. They were asked to complete the WHO questionnaire to establish the presence or absence of intermittent claudication. In addition, each patient's case notes were reviewed to establish the existence of definite peripheral vascular disease and to determine their risk factor profile. RESULTS--Forty six patients responded to the questionnaire, giving a response rate of 87%. Intermittent claudication was found in 10 SSc patients (21.7%) according to the questionnaire (two with diffuse and eight with limited SSc), compared with a prevalence rate of 4.6% for claudication in the EAS. Three SSc patients experienced clinical events attributable to occlusion of a major artery proven on angiography. Four patients had hypertension, there were three current and four ex-smokers, and two had increased total cholesterol. None of these patients had diabetes. CONCLUSIONS--This study demonstrated a greater prevalence of macrovascular disease in patients with SSc than had been found in a neighbouring population.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• GARIN, M. C., HIGHLAND, K. B., SILVER, R. M., STRANGE, C. (2009). Limitations to the 6-Minute Walk Test in Interstitial Lung Disease and Pulmonary Hypertension in Scleroderma. The Journal of Rheumatology 36: 330-336 [Abstract] [Full Text]  
• Hettema, M. E., Bootsma, H., Kallenberg, C. G. M. (2008). Macrovascular disease and atherosclerosis in SSc. Rheumatology (Oxford) 47: 578-583 [Abstract] [Full Text]  
• Szucs, G., Timar, O., Szekanecz, Z., Der, H., Kerekes, G., Szamosi, S., Shoenfeld, Y., Szegedi, G., Soltesz, P. (2007). Endothelial dysfunction precedes atherosclerosis in systemic sclerosis--relevance for prevention of vascular complications. Rheumatology (Oxford) 46: 759-762 [Abstract] [Full Text]  
• Bartoli, F., Angotti, C., Fatini, C., Conforti, M. L., Guiducci, S., Blagojevic, J., Melchiorre, D., Fiori, G., Generini, S., Damjanov, N., Rednic, S., Pignone, A., Castellani, S., Abbate, R., Matucci Cerinic, M. (2007). Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis. Rheumatology (Oxford) 46: 772-775 [Abstract] [Full Text]  
• Moyssakis, I., Gialafos, E., Vassiliou, V., Taktikou, E., Katsiari, C., Papadopoulos, D. P., Sfikakis, P. P. (2005). Aortic stiffness in systemic sclerosis is increased independently of the extent of skin involvement. Rheumatology (Oxford) 44: 251-254 [Abstract] [Full Text]  
• Cheng, K.-S., Tiwari, A., Boutin, A., Denton, C. P., Black, C. M., Morris, R., Hamilton, G., Seifalian, A. M. (2003). Carotid and femoral arterial wall mechanics in scleroderma. Rheumatology (Oxford) 42: 1299-1305 [Abstract] [Full Text]  
• Young, V., Ho, M., Vosper, H., Belch, J. J. F., Palmer, C. N. A. (2002). Elevated expression of the genes encoding TNF-{alpha} and thromboxane synthase in leucocytes from patients with systemic sclerosis. Rheumatology (Oxford) 41: 869-875 [Abstract] [Full Text]  
• Dick, E A, Aviv, R, Francis, I, Hamilton, G, Baker, D, Black, C, Platts, A, Watkinson, A (2001). Catheter angiography and angioplasty in patients with scleroderma. Br. J. Radiol. 74: 1091-1096 [Abstract] [Full Text]  
• Wan, M. C., Moore, T., Hollis, S., Herrick, A. L. (2001). Ankle brachial pressure index in systemic sclerosis: influence of disease subtype and anticentromere antibody. Rheumatology (Oxford) 40: 1102-1105 [Abstract] [Full Text]  
• Della Rossa, A, Valentini, G, Bombardieri, S, Bencivelli, W, Silman, A J, D'Angelo, S, Cerinic, M M., Belch, J F, Black, C M, Becvar, R, Bruhlman, P, Cozzi, F, Czirjak, L, Drosos, A A, Dziankowska, B, Ferri, C, Gabrielli, A, Giacomelli, R, Hayem, G, Inanc, M, McHugh, N J, Nielsen, H, Scorza, R, Tirri, E, van den Hoogen, F H J, Vlachoyiannopoulos, P G (2001). European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Ann Rheum Dis 60: 585-591 [Abstract] [Full Text]  
• Herrick, A. L., Illingworth, K. J., Hollis, S., Gomez-Zumaquero, J. M., Tinahones, F. J. (2001). Antibodies against oxidized low-density lipoproteins in systemic sclerosis. Rheumatology (Oxford) 40: 401-405 [Abstract] [Full Text]  
• Sari-Kouzel, H., Hutchinson, C. E., Middleton, A., Webb, F., Moore, T., Griffin, K., Herrick, A. L. (2001). Foot problems in patients with systemic sclerosis. Rheumatology (Oxford) 40: 410-413 [Abstract] [Full Text]  
• Cutolo, M., Nobili, F., Sulli, A., Pizzorni, C., Briata, M., Faelli, F., Vitali, P., Mariani, G., Copello, F., Seriolo, B., Barone, C., Rodriguez, G. (2000). Evidence of cerebral hypoperfusion in scleroderma patients. Rheumatology (Oxford) 39: 1366-1373 [Abstract] [Full Text]  
• Ho, M., Veale, D., Eastmond, C., Nuki, G., Belch, J. (2000). Macrovascular disease and systemic sclerosis. Ann Rheum Dis 59: 39-43 [Abstract] [Full Text]  
• Stafford, L, Englert, H, Gover, J, Bertouch, J (1998). Distribution of macrovascular disease in scleroderma. Ann Rheum Dis 57: 476-479 [Abstract] [Full Text]